TR201716207A2 - Pharmaceutical formulations containing vilanterol and umeclidinium. - Google Patents
Pharmaceutical formulations containing vilanterol and umeclidinium. Download PDFInfo
- Publication number
- TR201716207A2 TR201716207A2 TR2017/16207A TR201716207A TR201716207A2 TR 201716207 A2 TR201716207 A2 TR 201716207A2 TR 2017/16207 A TR2017/16207 A TR 2017/16207A TR 201716207 A TR201716207 A TR 201716207A TR 201716207 A2 TR201716207 A2 TR 201716207A2
- Authority
- TR
- Turkey
- Prior art keywords
- umeclidinium
- vilanterol
- pharmaceutical formulations
- formulations containing
- dry powder
- Prior art date
Links
- FVTWTVQXNAJTQP-UHFFFAOYSA-N diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol Chemical compound C=1C=CC=CC=1C(C12CC[N+](CCOCC=3C=CC=CC=3)(CC1)CC2)(O)C1=CC=CC=C1 FVTWTVQXNAJTQP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229960004258 umeclidinium Drugs 0.000 title abstract 2
- DAFYYTQWSAWIGS-DEOSSOPVSA-N vilanterol Chemical compound C1=C(O)C(CO)=CC([C@@H](O)CNCCCCCCOCCOCC=2C(=CC=CC=2Cl)Cl)=C1 DAFYYTQWSAWIGS-DEOSSOPVSA-N 0.000 title abstract 2
- 229960004026 vilanterol Drugs 0.000 title abstract 2
- 239000000843 powder Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, Vilanterol ve Umeklidinyumdan oluşan, kuru toz formundaki farmasötik formülasyonlara ilişkindir.The present invention relates to pharmaceutical formulations in dry powder form comprising Vilanterol and Umeclidinium for use in respiratory tract ailments.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/16238A TR201716238A1 (en) | 2017-10-18 | 2017-10-20 | New pharmaceutical compositions. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/16203A TR201716203A1 (en) | 2017-10-20 | 2017-10-20 | New umeclidinium formulations. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201716207A2 true TR201716207A2 (en) | 2019-05-21 |
Family
ID=67954794
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/16203A TR201716203A1 (en) | 2017-09-30 | 2017-10-20 | New umeclidinium formulations. |
| TR2017/16209A TR201716209A2 (en) | 2017-09-30 | 2017-10-20 | New pharmaceutical compositions containing arformoterol and umeclidinium. |
| TR2017/16207A TR201716207A2 (en) | 2017-10-18 | 2017-10-20 | Pharmaceutical formulations containing vilanterol and umeclidinium. |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/16203A TR201716203A1 (en) | 2017-09-30 | 2017-10-20 | New umeclidinium formulations. |
| TR2017/16209A TR201716209A2 (en) | 2017-09-30 | 2017-10-20 | New pharmaceutical compositions containing arformoterol and umeclidinium. |
Country Status (1)
| Country | Link |
|---|---|
| TR (3) | TR201716203A1 (en) |
-
2017
- 2017-10-20 TR TR2017/16203A patent/TR201716203A1/en unknown
- 2017-10-20 TR TR2017/16209A patent/TR201716209A2/en unknown
- 2017-10-20 TR TR2017/16207A patent/TR201716207A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR201716203A1 (en) | 2019-05-21 |
| TR201716209A2 (en) | 2019-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL263709A (en) | Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use | |
| CY1120684T1 (en) | DRY DUST PREPARATION THAT CONTAINS A CORTICOSTEROIDS AND A BETA-ADRENERGIC FOR INHALATION | |
| DOP2017000306A (en) | PHARMACEUTICAL FORMULATIONS CONTAINING TENOFOVIR AND EMTRICITABINE | |
| BR112019007459A2 (en) | antifungal dry powders | |
| TR201909447T4 (en) | Aramkol salts. | |
| DK3412660T3 (en) | Sulfonamide derivative and pharmaceutical composition containing the same | |
| DK3426294T3 (en) | Pharmaceutical formulation comprising antibody, cyclodextrin and methionine | |
| CY1122473T1 (en) | HIGH DOSE OPTIMIZED MID-SALIZED TABLET | |
| DK3429559T3 (en) | Palatable compositions containing sodium phenylbutyrate and uses thereof | |
| WO2016140933A3 (en) | Immediate release soluble ibuprofen compositions | |
| AR108233A1 (en) | ORIC PHARMACEUTICAL COMPOSITIONS OF NICOTINAMIDE | |
| CO2018014217A2 (en) | Pharmaceutical compositions comprising safinamide | |
| PH12018501758A1 (en) | Oritavancin formulations | |
| CY1118277T1 (en) | STABLE PHARMACEUTICAL FORM PEXIGANANIS | |
| PH12018502139A1 (en) | Phosphaplatin liquid formulations | |
| CY1120192T1 (en) | UNIONS TO ENHANCE KNOWLEDGE FUNCTIONING | |
| TR201716207A2 (en) | Pharmaceutical formulations containing vilanterol and umeclidinium. | |
| CO2017003989A2 (en) | Herbicidal composition and process to prepare it | |
| EA202091403A1 (en) | 2-OXO-1-PYRROLIDINYLIMIDAZOTHIAZOLE DERIVATIVES | |
| TR201714725A1 (en) | DRY POWDER FORMULATION WITH BETA-2 AGONIST AND ANTICOLINERGIC | |
| TR201714728A1 (en) | Dry powder formulation containing Beta-2 Agonist and Corticosteroid. | |
| TR201714893A1 (en) | Dry powder composition containing Beta-2 Agonist and Corticosteroid. | |
| TR201716155A1 (en) | Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist. | |
| PH12018501991A1 (en) | Pharmaceutical composition for use in treating fibrosis | |
| TR200907913A2 (en) | Pharmaceutical composition in dry powder form for inhalation |